The route to implementation of the proposed Unitary Patent system promised has been far from easy. With it now projected to come into effect in mid-2022, we set out the answers to some frequently asked questions in our latest white paper 'The Unitary Patent: A practical guide'.
Female technology (FemTech) is becoming big business with health and wellness apps, software and diagnostic products promising to revolutionise women’s health. Asma Mejri sets out strategic IP advice for FemTech start-ups.
Owners of well-known trademarks seeking to introduce a new product and service may find themselves blocked by ‘trademark squatting’, where a third party has already applied for an identical or similar trademark. A recent ruling by the Dutch Higher Court illustrates why and how to take action.
The United Arab Emirates (UAE) will join the Madrid System in December 2021, becoming the 109th member state of the international trademark registration system.
The EPO’s Enlarged Board of Appeal has issued its highly anticipated decision on the patentability of computer-implemented simulations. Martin Kohrs examines the decision and its implications.
The need to file evidence of use can crop up in many cases and the requirement to show historic use can cause problems for businesses. Preparation is critical to success.
In our white paper 'Best practices in trademark auditing: a practical guide', we set out the steps to take to put a trademark auditing programme in place that will help your business to streamline and exploit its portfolio.
Earlier this month, EUIPO’s Board of Appeal ruled on an opposition between German drink brand Jägermeister and French company Les Bordes over ownership of a stylised Hubertus stag.
The German Federal Constitutional Court has cleared the way for Germany to finally implement the Agreement on a Unified Patent Court (UPCA). In so doing, the unitary patent and court system could come into being as of mid-2022.
International registration systems are an important route for the protection of designs. Anne-Catherine Schihin introduces a new tool to protect design rights in the countries of the former USSR.
By removing the need for prior approval by ANVISA, the patent process for pharmaceutical and biotechnology products has been shortened and associated costs reduced.
Unlike trademark registration systems, which are national or regional by nature, the internet offers a global and potentially limitless market. Businesses with the same or confusingly similar company or product names can face a considerable challenge to mitigate the risks of brand confusion online.